Bruce Goldman writing for Stanford Medicine reports that a study led by Cornelia Weyand uncovered that shutting down a faulty molecular mechanism in mice could curb the damage caused by rheumatoid arthritis. This pre-clinical investigation holds considerable future translational promise. Follow the link below to read Mr. Goldman’s fascinating article.

Lead Research/Investigator

Cornelia Weyand

https://profiles.stanford.edu/cornelia-weyand
Source: Med Stanford Edu

Pin It on Pinterest